CAPASTAT SULFATE (Akorn)


Welcome to the PulseAid listing for the CAPASTAT SULFATE drug offered from Akorn. This Antimycobacterial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Akorn
NON-PROPRIETARY NAME: Capreomycin
SUBSTANCE NAME: CAPREOMYCIN SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antimycobacterial [EPC]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-08-01
END MARKETING DATE: 0000-00-00


CAPASTAT SULFATE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCAPASTAT SULFATE from Akorn
LABELER NAME: Akorn
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/1)
START MARKETING DATE: 2009-08-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17478-080_2b14f1a3-f8d6-45e8-a31a-89dc25d5c7f8
PRODUCT NDC: 17478-080
APPLICATION NUMBER: NDA050095

Other CAPREOMYCIN SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AkornCAPASTAT SULFATE